Mostrar el registro sencillo del ítem

dc.contributor.author
Landoni, Verónica Inés  
dc.contributor.author
Martire Greco, Daiana  
dc.contributor.author
Rodriguez Rodrigues, Nahuel Emiliano  
dc.contributor.author
Chiarella, Paula  
dc.contributor.author
Schierloh, Luis Pablo  
dc.contributor.author
Isturiz, Martín Amadeo  
dc.contributor.author
Fernández, Gabriela Cristina  
dc.date.available
2018-05-16T02:24:08Z  
dc.date.issued
2016-01-14  
dc.identifier.citation
Landoni, Verónica Inés; Martire Greco, Daiana; Rodriguez Rodrigues, Nahuel Emiliano; Chiarella, Paula; Schierloh, Luis Pablo; et al.; Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function; Portland Press; Clinical Science; 130; 4; 14-1-2016; 259-271  
dc.identifier.issn
0143-5221  
dc.identifier.uri
http://hdl.handle.net/11336/45318  
dc.description.abstract
Secondary infections due to post-sepsis immunosuppression are a major cause of death in patients with sepsis.Repetitive inoculation of increasing doses of lipopolysaccharide (LPS) into mice mimics the immunosuppressionassociated with sepsis. Myeloid-derived suppressor cells (MDSCs, Gr-1+ CD11b+) are considered a majorcomponent of the immunosuppressive network, interfering with T-cell responses in many pathological conditions.We used LPS-immunosuppressed (IS) mice to address whether MDSCs acquired their suppressive ability in thebone marrow (BM) and whether they could migrate to lymph nodes (LNs) to exert their suppressive function. Ourresults showed that Gr-1+ CD11b+ cells of IS mice already had the potential to inhibit T-cell proliferation in the BM.Moreover, soluble factors present in the BM from IS mice were responsible for inducing this inhibitory ability incontrol BM cells. In addition, migration of Gr-1+ CD11b+ to LNs in vivo was maximal when cells obtained from theBM of IS mice were inoculated into an IS context. In this regard, we found chemoattractant activity in cell-free LNextracts (LNEs) from IS mice and an increased expression of the LN-homing chemokine receptor C?C chemokinereceptor type 7 (CCR7) in IS BM Gr-1+ CD11b+ cells. These results indicate that Gr-1+ CD11b+ cells found in BMfrom IS mice acquire their suppressive activity in the same niche where they are generated, and migrate to LNs toexert their inhibitory role. A better understanding of MDSC generation and/or regulation of factors able to inducetheir inhibitory function may provide new and more effective tools for the treatment of sepsis-associatedimmunosuppression.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Portland Press  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Antigens  
dc.subject
Bone Marrow  
dc.subject
Cd11b  
dc.subject
Lymph Nodes  
dc.subject
Sepsis  
dc.subject
T Lymphocytes  
dc.subject.classification
Otras Ciencias Biológicas  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.subject.classification
Inmunología  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Immature myeloid Gr-1+ CD11b+ cells from lipopolysaccharide-immunosuppressed mice acquire inhibitory activity in the bone marrow and migrate to lymph nodes to exert their suppressive function  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-05-03T14:12:21Z  
dc.identifier.eissn
1470-8736  
dc.journal.volume
130  
dc.journal.number
4  
dc.journal.pagination
259-271  
dc.journal.pais
Reino Unido  
dc.journal.ciudad
Londres  
dc.description.fil
Fil: Landoni, Verónica Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Martire Greco, Daiana. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Rodriguez Rodrigues, Nahuel Emiliano. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Chiarella, Paula. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Schierloh, Luis Pablo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Isturiz, Martín Amadeo. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Fernández, Gabriela Cristina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.journal.title
Clinical Science  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://www.clinsci.org/content/130/4/259.long  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1042/CS20150653